Precision BioSciences, Inc.
General ticker "DTIL" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $36.6M (TTM average)
Precision BioSciences, Inc. follows the US Stock Market performance with the rate: 27.0%.
Estimated limits based on current volatility of 3.9%: low 4.80$, high 5.19$
Factors to consider:
- Total employees count: 109 as of 2023
- Top business risk factors: Insufficient cash runway, High R&D costs, Financing risks, Market acceptance, Regulatory and compliance
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.86$, 8.91$]
- 2025-12-31 to 2026-12-31 estimated range: [2.71$, 8.07$]
Financial Metrics affecting the DTIL estimates:
- Positive: with PPE of -1.5 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -192.98 <= 0.33
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 4.99
- Negative: negative Industry operating cash flow (median)
- Positive: -4.48 < Investing cash flow per share per price, % of -0.71
Short-term DTIL quotes
Long-term DTIL plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $25.10MM | $48.73MM | $68.70MM |
| Operating Expenses | $87.41MM | $92.46MM | $94.86MM |
| Operating Income | $-62.31MM | $-43.74MM | $-26.16MM |
| Non-Operating Income | $-10.60MM | $1.21MM | $33.33MM |
| Interest Expense | $1.11MM | $2.23MM | $1.78MM |
| R&D Expense | $46.12MM | $53.38MM | $59.56MM |
| Income(Loss) | $-72.91MM | $-42.53MM | $7.17MM |
| Profit(Loss)* | $-111.64MM | $-61.32MM | $7.17MM |
| Stockholders Equity | $60.43MM | $18.86MM | $56.39MM |
| Assets | $238.17MM | $159.78MM | $136.39MM |
| Operating Cash Flow | $-45.75MM | $-84.11MM | $-58.45MM |
| Capital expenditure | $3.32MM | $2.28MM | $0.25MM |
| Investing Cash Flow | $-3.32MM | $5.83MM | $-0.21MM |
| Financing Cash Flow | $94.98MM | $5.39MM | $50.45MM |
| Earnings Per Share** | $-38.10 | $-15.96 | $1.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.